Speech-Language Pathologists in Pataskala, OH Accepting Medicare

5 Speech-Language Pathologists found. Showing 1 - 5

Robin Jacobson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 927 South St Unit A, Pataskala, OH 43062 Phone: 740-927-3941

Mrs. Keli R Massie, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 391 S. High Street, Pataskala, OH 43062 Phone: 740-927-3861

Mari Kay Dono, MS/CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6539 Summit Rd Sw, Pataskala, OH 43062 Phone: 740-927-6926    Fax: 740-927-9043

Kelsey Dailey, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 927 South St Unit A, Pataskala, OH 43062 Phone: 740-927-3941

Martha Adams Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6507 Summit Rd Sw, Pataskala, OH 43062 Phone: 740-927-3268

News Archive

HealthPlanOne adds Employer Solutions offering to portfolio of services

HealthPlanOne, a leading national provider of private healthcare exchange services for retirees and individuals, today announced the addition of its Employer Solutions offering to its portfolio of services.

Polysubstance-involved opioid overdose deaths are more common among youth, study shows

Results of a new study show that opioid overdose deaths involving more than one substance (polysubstances) are more common than opioid-only overdose deaths among youth.

New licensing agreement to promote discovery in health IT and improve economic Growth

The Regenstrief Institute Inc., an international leader in electronic medical records and health information exchange research, development and operations, is licensing its Indiana Network for Patient Care and DOCS4DOCS clinical results delivery software to a subsidiary of the Indiana Health Information Exchange. This licensing agreement represents the single most significant transfer of discovery out of an academic medical informatics research setting to a commercial enterprise in the history of Indiana's health information technology sector and the national evolution of health information exchange.

Female patients with esophageal cancer have superior response to treatment, study reveals

Female patients with locally advanced esophageal cancer that is treated with chemotherapy and radiation therapy before surgery are more likely to have a favorable response to the treatment than male patients are, and women are less likely to experience cancer recurrence, according to a study published online today in The Annals of Thoracic Surgery.

Agennix, DSM sign new contract to manufacture talactoferrin for NSCLC

DSM Pharmaceutical Products, the custom manufacturing business of Royal DSM N.V., and Agennix AG have signed a new contract under which DSM will continue to manufacture talactoferrin for Agennix at commercial levels.

Read more Medical News

› Verified 8 days ago